Effects of chemokine-like factor 1 on vascular smooth muscle cell migration and proliferation in vascular inflammation

Atherosclerosis

Volumn 226, Issue 1, 2013, Pages 49-57

  Zhang, Tao ^a   Zhang, Xiaoming ^a   Yu, Weidong ^a   Chen, Jian ^b   Li, Qingle ^a   Jiao, Yang ^a   He, Peiying ^a   Shen, Chenyang ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b INSTITUTE OF ELECTRONICS   (China)

Author keywords

Atherosclerosis; Chemokine like factor 1; Migration and proliferation; Neointima formation; Vascular smooth muscle cell

Indexed keywords

CHEMOKINE; CHEMOKINE LIKE FACTOR 1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERY INJURY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULITIS;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINES; HUMANS; MALE; MARVEL DOMAIN-CONTAINING PROTEINS; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; VASCULITIS;

EID: 84871387861     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.023     Document Type: Article

References (27)

1. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 2006, 113:e463-e654.
2. Schirmang T.C., Ahn S.H., Murphy T.P., et al. Peripheral arterial disease: update of overview and treatment. Med Health R I 2009, 92:398-402.
3. Surowiec S.M., Davies M.G., Eberly S.W., et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005, 41:269-278.
4. Conte M.S., Bandyk D.F., Clowes A.W., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006, 43:742-751.
5. Smith T.P. Atherosclerosis and restenosis: an inflammatory issue. Radiology 2002, 225:10-12.
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
7. Sprague A.H., Khalil R.A. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009, 78:539-552.
8. Newby A.C., Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J Pathol 2000, 190:300-309.
9. Aukrust P., Halvorsen B., Yndestad A., et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008, 28:1909-1919.
10. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
11. Han W., Lou Y., Tang J., et al. Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem J 2001, 357:127-135.
12. Han W.L., Rui M., Zhang Y.M., et al. Stimulatory effect of chemokine-like factor 1 (CKLF1) on the growth of bone marrow cells. Acta Academiae Medicinae Sinicae 2001, 23:119-122.
13. Tan Y.X., Han W.L., Chen Y.Y., et al. Chemokine-like factor 1, a novel cytokine, contributes to airway damage, remodeling and pulmonary fibrosis. Chin Med J (Engl) 2004, 117:1123-1129.
14. Chowdhury M.H., Nagai A., Terashima M., et al. Chemokine-like factor expression in the idiopathic inflammatory myopathies. Acta Neurol Scand 2008, 118:106-114.
15. Ji Y., Zhang H., Yuan H., et al. Expression of chemokine like factor-1 in nephridial tissue of lupus nephritis. J Cent South Univ Med Sci 2007, 32:490-493.
16. Wang Y., Zhang Y., Yang X., et al. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4). Life Sci 2006, 78:614-621.
17. Simons M., Edelman E.R., DeKeyser J.L., et al. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992, 359:67-70.
18. Wolff R.A., Ryomoto M., Stark V.E., et al. Antisense to transforming growth factor-beta1 messenger RNA reduces vein graft intimal hyperplasia and monocyte chemotactic protein 1. J Vasc Surg 2005, 41:498-508.
19. Mitra A.K., Del Core M.G., Agrawal D.K. Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies. Can J Physiol Pharmacol 2005, 83:701-715.
20. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones 2007, 39:86-93.
21. Willis A.I., Pierre-Paul D., Sumpio B.E., et al. Vascular smooth muscle cell migration: current research and clinical implications. Vasc Endovascular Surg 2004, 38:11-23.
22. Kong L.L., Hu J.F., Zhang W., et al. Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat. Neurosci Lett 2011, 505:14-18.
23. Shao L., Li T., Mo X., et al. Expressional and functional studies of CKLF1 during dendritic cell maturation. Cell Immunol 2010, 263:188-195.
24. Niessner A., Weyand C.M. Dendritic cells in atherosclerotic disease. Clin Immunol 2010, 134:25-32.
25. Jiao Y., Shen C.Y., Zhang X.M. The expression of chemokine-like factor 1 in human atherosclerotic plaques. Chin J Surg 2009, 47:1654-1657.
26. Stadius M.L., Rowan R., Fleischhauer J.F., et al. Time course and cellular characteristics of the iliac artery response to acute balloon injury. An angiographic, morphometric, and immunocytochemical analysis in the cholesterol-fed New Zealand white rabbit. Arterioscler Thromb 1992, 12:1267-1273.
27. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008, 28:1950-1959.